
HNGE Stock Forecast & Price Target
HNGE Analyst Ratings
Bulls say
Hinge Health Inc. demonstrated strong financial performance with a nearly 44% year-over-year growth in calculated billings, reaching $671 million, alongside a 25% increase in client count to over 2,800, reflecting its effective market penetration. The company's revenue of $170.7 million also exceeded expectations, growing 46% year-over-year, and its guidance for future revenues indicates a positive outlook with projections of $732 million to $742 million for the upcoming year, a 25% increase at the midpoint. Furthermore, Hinge Health's ongoing utilization growth within its existing client base suggests a solid foundation for market share expansion in the coming years.
Bears say
The analysis reveals a negative outlook for Hinge Health's stock, primarily due to the anticipated impact of a macro-driven weak spending environment in the second half of 2025, which could lead to slower growth in FY26. Despite guidance indicating higher non-GAAP operating income and strong gross margins that exceed consensus estimates, concerns regarding the dependency on employee utilization for billing growth highlight the risk associated with the company's business model. Additionally, competitive challenges may arise from potential clients delaying decisions due to budgetary constraints, further complicating Hinge Health's growth prospects in the immediate future.
This aggregate rating is based on analysts' research of Hinge Health Inc and is not a guaranteed prediction by Public.com or investment advice.
HNGE Analyst Forecast & Price Prediction
Start investing in HNGE
Order type
Buy in
Order amount
Est. shares
0 shares